The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 308.00
Ask: 308.50
Change: 14.50 (4.97%)
Spread: 0.50 (0.162%)
Open: 298.00
High: 308.00
Low: 285.50
Prev. Close: 291.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adrian Whitfield to step down as CEO

1 Jul 2014 07:00

RNS Number : 9651K
Synthomer PLC
01 July 2014
 



July 1st 2014

Adrian Whitfield to step down as Group Chief Executive in June 2015

Synthomer plc ('Synthomer' or the 'Company') today announces that Adrian Whitfield, Group Chief Executive, will step down after eight years with the Company. To allow sufficient time for a replacement to be found and an orderly transition to take place, Adrian will remain as Group Chief Executive and on the Board until 30 June 2015.

 

The Board will conduct a comprehensive search for the Company's next Chief Executive and a further announcement will be made in due course.

Neil Johnson, Chairman, said: "Over the past 8 years, Adrian has overseen Synthomer's transformation from a small, diversified chemical business to a world leading producer of aqueous polymers. He led the highly successful acquisition of PolymerLatex in 2011 and during his tenure the Company's revenues have more than doubled to over £1 billion.

 

Today the business has a robust balance sheet, strong cashflow and excellent management team. On behalf of the board, I would like to thank Adrian for his hard work and commitment. We are sorry to see him go and wish him all the best for the future."

Adrian Whitfield said:

 

"The 8 years that I have spent with Synthomer have been among the most rewarding of my career. I am proud of the significant turnaround that has been achieved and our track record of strong growth. I have been fortunate to work with a fantastic team and Synthomer's dedicated employees around the world.

 

With the business on a solid platform supported by a clear strategy for future growth, now is the right time in my career to step down and allow someone else to take Synthomer forward. While I remain completely focused on the job until my successor is in place, my thanks go to the Board and everyone at Synthomer for supporting me in leading the Company through such a successful period of its development."

 

 

Enquiries:

 

Synthomer plc

Neil Johnson, Chairman

 

Adrian Whitfield, Group Chief ExecutiveDavid Blackwood, Chief Financial Officer

 

 

 

 

+44 (0) 20 3603 5220 (c/o Pendomer)

 

+44 (0) 1279 442791

Pendomer CommunicationsCharles Armitstead

 

+44 (0) 20 3603 5224

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEASKEDAPLEFF
Date   Source Headline
16th Jun 202010:11 amRNSQ2 trading update
11th May 20205:21 pmRNSHolding(s) in Company
11th May 20209:03 amRNSDirector/PDMR Shareholding
11th May 20209:02 amRNSDirector/PDMR Shareholding
11th May 20208:59 amRNSDirector/PDMR Shareholding
11th May 20208:58 amRNSDirector/PDMR Shareholding
29th Apr 20203:17 pmRNSResult of AGM
29th Apr 20207:00 amRNSQ1 Trading and COVID-19 Update
1st Apr 20202:44 pmRNSCompletion of OMNOVA acquisition
1st Apr 20207:00 amRNSAnnual Financial Report
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
30th Mar 20207:00 amRNSAppointment of Deputy Chair and Chair-elect
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
26th Mar 202010:17 amRNSEuropean Commission clearance for OMNOVA
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20209:50 amRNSDirector/PDMR Shareholding
13th Mar 20205:29 pmRNSDirector/PDMR Shareholding
9th Mar 20202:45 pmRNSHolding(s) in Company
5th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
31st Jan 20209:36 amRNSDirector Declaration
15th Jan 20202:21 pmRNSAcquisition of OMNOVA receives EC clearance
6th Dec 20197:00 amRNSAppointment of Broker
13th Nov 20192:53 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSDirector Declaration
25th Oct 20197:00 amRNSQ3 Trading Update
22nd Oct 20197:00 amRNSAGM Statement
11th Oct 20197:00 amRNSOmnova shareholders approval
14th Aug 20193:25 pmRNSHolding(s) in Company
13th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSInterim Results for 6 months ended 30 June 2019
2nd Aug 201910:29 amRNSHolding(s) in Company
1st Aug 20199:05 amRNSHolding(s) in Company
31st Jul 201910:51 amRNSResults of Extraordinary General Meeting
30th Jul 20191:07 pmRNSDirector/PDMR Shareholding
30th Jul 20191:03 pmRNSDirector/PDMR Shareholding
30th Jul 20191:02 pmRNSDirector/PDMR Shareholding
30th Jul 20191:01 pmRNSDirector/PDMR Shareholding
30th Jul 201912:59 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:55 pmRNSDirector/PDMR Shareholding
30th Jul 201912:54 pmRNSDirector/PDMR Shareholding
30th Jul 201912:53 pmRNSDirector/PDMR Shareholding
30th Jul 201912:52 pmRNSDirector/PDMR Shareholding
30th Jul 201912:51 pmRNSDirector/PDMR Shareholding
30th Jul 201912:50 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201911:31 amRNSResults of Rump Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.